Cellebrite Q2: This 33% Selloff Looks Like An Overreaction (NASDAQ:CLBT)
· seekingalpha.com
Cellebrite DI Ltd. experienced a 33% post-earnings drop, but I view this as an overreaction given its robust fundamentals. Click for this CLBT stock update.
I didn’t think that Cellebrite DI Ltd. ( CLBT ) was a dirt cheap stock; in my last analysis , I mentioned that the stock had a “reasonable valuation,” but...